In addition, ACLY, NKIRAS2, XPO1 and tumor purity were significantly positively correlated (p < 0.001), which further indicates that ACLY, NKIRAS2 and XPO1 may be potential targets for the treatment of bladder cancer. This evidence concerns the gene XPO1 and neoplasm.